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A B S T R A C T
Galloway–Mowat Syndrome (GMS) is an autosomal recessively inherited condition which manifests
with severe encephalopathy, featuring microcephaly, developmental delay, and early-onset intractable
epilepsy. Patients typically show also renal involvement from the onset. We report two siblings with
GMS presenting with early-onset, intractable epilepsy and neurological deterioration, later followed by
renal impairment. In both patients intractable epilepsy started during the ﬁrst months of life and
included a combination of spasms, focal and myoclonic/atonic seizures, along with psychomotor
retardation and dysmorphic features. One of the patient died from fulminating renal failure at age 6
years. The other patient developed only isolated proteinuria from the age 3 years. Our cases differ from
‘classic’ GMS, as manifested the clinical and laboratory features of renal involvement only some years
later the onset of epilepsy and neurological symptoms. Therefore, the diagnosis of GMS should be
considered in infants with intractable epilepsy, encephalopathy, and multiple neurological deﬁcits, also
in absence of renal manifestations. The literature data about the electroclinical features of epilepsy in
GMS are also reviewed.
 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Galloway–Mowat syndrome (GMS; OMIM 251300) is a rare
autosomal recessive condition ﬁrst described in 19681 and
characterized by the association of nephrotic syndrome and
central nervous system involvement. The nephrotic syndrome
occurs in the ﬁrst months of life and is typically steroid-resistant,
followed by constant and rapid deterioration of renal function. The
degree of renal anatomopathological damage is variable and
ranges from minimal changes up to diffuse mesangial sclerosis.2,3
Death usually occurs within few years from the onset.1–4 The
spectrum of neurological manifestations is wide and includes
microcephaly, severe developmental delay, and structural brain
abnormalities, such as malformations of cortical development,* Corresponding author at: Armenian Republican Epilepsy Centre Erebouni,
Yerevan State Medical University, 14 Titogradyan str., 0087 Yerevan, Armenia.
E-mail addresses: ynune@yahoo.com, nunepilepsy@gmail.com
(N.S. Yeghiazaryan).
1 These authors contributed equally to this work.
1059-1311/$ – see front matter  2010 British Epilepsy Association. Published by Else
doi:10.1016/j.seizure.2009.12.002hypomyelination, and cerebellar atrophy.5,6 We report two
siblings presenting with early-onset, intractable epilepsy and
neurological deterioration, followed by renal impairment only
some years from the clinical onset.
2. Case reports
2.1. Patient 1
The proband is a boy born from non-consanguineous parents
after full-term pregnancy complicated by a risk of abortion at the
30th week of gestation. Birth weight was 3060 g, birth length
50 cm, occipito-frontal circumference 35 cm (50th percentile).
Neonatal period and growth were initially normal. At the age of 2
months, the boy started suffering from daily epileptic spasms. At
that time, EEGs showed a typical pattern of hypsarrhythmia
(Fig. 1a and b). Neurological examination revealed severe
psychomotor delay, prominent axial hypotonia, no head mainte-
nance, poor eye contact, microcephaly (36 cm; <3rd percentile),
mild dysmorphisms, namely, hypertelorism, long philtrum,
protruding tongue, and ﬂoppy ears. Routine blood analyses,vier Ltd. All rights reserved.
Fig. 1. (a) Interictal EEGs of patient 1 (at age 5 months) showing hypsarrhytmia at awake (b) intermixed to suppression-burst pattern during sleep. (c) EEG recordings of
patient 2 (at age 3 years) showing slowed background activity and interictal diffuse andmultifocal (bilateral frontal and occipital) epileptiform abnormalities (d) ictal diffuse
polyspikes preceding the epileptic spasm.
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lysosomal enzymes, fundoscopy, and karyotyping were normal.
Within few months, also other seizure types appeared, i.e., head
drops and focal seizures with chewing automatisms. We observed
the boy for the ﬁrst time at 3 years of life. Neurological
examination revealed severe psychomotor delay, spastic tetrapar-
esis, and dystonic–hyperkinetic movements involving the face and
the arms, facilitated by tactile stimuli. At that time, he showed
daily epileptic spasms as well as focal seizures with eye deviation
and oral automatisms. EEG revealed diffusely slowed background
activity with multifocal epileptiform abnormalities, prevalent on
the right temporo-central areas. Brain MRI revealed mild atrophy
of both temporal lobes and hippocampal malrotation. An intensive
metabolic screening (urinary, serum and CSF aminoacids; serum
and CSF lactate and pyruvate; serum biotidinase, acylcarnitine,
very long chain fatty acids; urinary organic amino acids,
mucopolysaccharides; coenzyme Q10 in muscle tissue), serologi-
cal (TORCH complex) and hormonal (ACTH, cortisol, 17OH-
progesterone, DHEAS, delta-4-androstenedione, renin, aldoste-
rone) screening were normal. Therapy with several anticonvul-
sants (AEDs), including valproate, vigabatrin, lamotrigine, and
nitrazepam-used alone or in combination-was ineffective. At age 5
years the patient developed facial and leg edema due to nephrotic
syndrome (selective glomerular proteinuria: 4.14 g/day, n.v.: 0–
8 mg/dL; serum hypoproteinemia: 4 g/dL, n.v. 5.5–9.0 g/dL,
hypoalbuminemia (3.1 g/dL, n.v. 3.5–5.5). Renal ultrasound was
unremarkable but renal biopsy showed segmental focal glomer-
ulosclerosis. The patient was treated with corticosteroids and
cyclophosphamide but showed no response. He died from renal
insufﬁciency at 6 years of life.2.2. Patient 2
The 3-year-old brother of patient 1 was born after full-term
pregnancy, complicated by a risk of abortion at 24 weeks of
gestation. Birth growth parameters were normal; occipito-frontal
circumference was 33 cm (<10th percentile). Generalized hypo-
tonia and bilateral neurosensory hypoacusia were also observed at
the birth. Afterwards, prominent psychomotor delay became
evident. At age 3 months daily epileptic spasms started. EEG
recordings showed a pattern of hypsarrhythmia. Treatment with
ACTH and then with vigabatrin gave partial beneﬁt. Within few
months, other seizure types, namely, complex partial seizureswith
upward and left eye deviation accompanied by oral automatisms,
and erraticmyoclonus alsomanifested. At examination, the patient
showed slight dysmorphic features (i.e., low-set ears, narrow
forehead, and long philtrum), microcephaly (46 cm; <3 percen-
tile), severe psychomotor delay, diffuse axial hypotonia, lower
spastic paraparesis, bilateral hypoacusia, and impaired vision.
Video-poligraphy showed diffusely slowed background, interictal
generalized and multifocal, namely bilateral frontal and occipital,
and generalized spikes preceding the spasm (Fig. 1c and d).
Polytherapywith valproate, lamotrigine, and levetiracetamwas
poorly effective. MRI revealed diffuse hypomyelination and
hypoplasia of cerebellar vermis and corpus callosum. Visual
evoked potentials were delayed whereas electroretinogram,
electromyography, and nerve conduction velocities were unre-
markable. Karyotyping, subtelomere FISH, and testing of congeni-
tal nephrotic syndromes genes (NPHS1, NPHS2, LAMB2) were
normal. At the last follow-up, at age 3 years, the boy presented
with proteinuria (1.2 g/dl) with normal serum protein, creatinine,
Table 1
Clinical, neurophysiological, and pathological ﬁndings of the GMS patients with epilepsy reported in the literature.
References Onset of
isolated
proteinuria
Onset of
nephrotic
syndrome
Dysmorphic features Neurological status Seizure
onset
Seizure
type (s)
Neuroimaging EEG
abnormalities
AEDs/response Pathological
ﬁndings
Outcome
Robain et al.9 – 1 day Absent Not reported 6 days Myoclonus NA Multifocal N/A/Absent Mesangial
ﬁbrosclerosis;
Pachigyria
Died at
3 months
Roos et al.8—
Case 1
1 year 2 years Bristly hair, bilateral
club feet
DD, hypotonia,
absent eye contact,
pyramidal signs
6 months Spasms Diffuse brain
atrophy
Generalized N/A/Poor FSGS;
polimicrogyria
Died at
3 years
Roos et al.8—
Case 2
1 year NA Not reported DD, hypotonia
pyramidal signs
3 months Spasms,
myoclonus
Normal SBP ACTH,
Nitrazepam/
Absent
NA NA
Sano et al.7 16 months 34 months Abnormal-shaped
skull, coarse hair,
narrow forehead large
low-set ears,
almond-shaped eyes,
low nasal bridge,
pinched nose, thin lips,
micrognathia
DD, hypotonia,
absent eye contact
10 months N/A Diffuse brain
atrophy
Generalized VPA/Poor FSGS, capillary
microaneurysms,
mesangiolysis; NA
Alive
35 months
Nishikawa
et al.13
– 53 days Hypoplasic nails on
toes, limited elbow
ﬂexion, rocker-bottom
heels
DD, pyramidal signs At birth Myoclonus,
focal, clonic
Cerebellar
hypoplasia,
colpocephaly
SBP PB, VPA, CBZ,
CLZ, B6/Absent
NA Died at
80 days
de Vries
et al.3—Case 1
– 2.5 years Facial asymmetry,
broad alveolar ridges,
single left palmar
crease
DD, hypotonia,
nystagmus
extrapyramidal signs
9 weeks Spasms,
myoclonus
Bilateral fronto-
temporal
hypoplasia
NA NA Glomerular sclerosis,
mesangial expansion,
patchy tubular
atrophy, chronic
inﬂammatory
inﬁtrates; NA
Died at
4 year
Nakazato
et al.10—Case 2
– 21 months Convergent strabismus,
narrow forehead
DD 11 months NA Frontal lobe
atrophy
Focal NA NA Alive
35 months
Nakazato
et al.10—Case 4
– 11 months Not reported DD 2 months NA Frontal lobe
atrophy
Hypsarrhythmia N/A/Poor FSGS; NA Died at
23 months
Sartelet et al.12 9 months 3 years,
8 months
Micrognathia, receding
forehead, large mouth,
large and ﬂoppy ears
DD, hypotonia 9 months Tonic–clonic Cerebellar
vermis atrophy
NA VPA/Good FSGS, collapsing
glomerulopathy; NA
Died at
3 years,
11 months
Akhtar et al.11 – 5 years High narrow forehead,
almond-shaped eyes,
large, low-set ears,
micrognathia, high
arched palate
DD, hypotonia
hemiplegia
5 years Tonic–clonic Normal NA NA NA NA
Present paper—
Case 1
– 5 years Hypertelorism, long
philtrum, protruding
tongue, ﬂoppy ears
DD, axial hypotonia
spastic tetraparesis,
extrapyramidal signs
2 months Spasms,
atonic, focal
Bilateral temporal
hypoplasia,
hippocampal
malrotation
Hypsarrhythmia;
multifocal
VPA, VGB, LTG,
Nitrazepam/
Absent
FSGS; NA Died at
6 years
Present paper—
Case 2
3 years – Low-set ears, narrow
forehead, long philtrum
DD, hypoacusia,
axial hypotonia,
lower spastic
paraparesis,
impaired vision
2 months Spasms,
myoclonus,
focal
Hypomyelination,
inferior vermis and
corpus callosum
hypoplasia
Hypsarrhythmia;
multifocal
ACTH, VGB, VPA,
LTG, LEV/Absent
NA Alive
DD=developmental delay; EEG=electroencephalography; SBP= suppression-burst pattern; NA=not available; FSGS=Focal segmental glomerular sclerosis; VPA=valproic acid; VGB=vigabatrin, LTG= lamotrigine,
LEV= levetiracetam; ACTH=adrenocorticotropic hormone; CBZ= carbamazepine; CLZ= clonazepam
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M. Pezzella et al. / Seizure 19 (2010) 132–135 135and urea. Renal ultrasound was unremarkable. Treatment with
ubiquinone was started.
3. Discussion
In the original description, GMS was reported as a clinical triad
of nephrotic syndrome, neurological manifestations, and hiatus
hernia.1 Since then more than 50 cases with GMS (‘nephrosis-
microcephaly syndrome’) have been reported and hiatus hernia is
no longer considered a key clinical feature.2–4 Therefore, the co-
occurrence in infants of renal impairment (i.e., nephrotic
syndrome) and central nervous system abnormalities, such as
defects of neuronal migration, cerebellar atrophy, hypomyelina-
tion, clinically associated to microcephaly, psychomotor delay,
severe epilepsy, and mild dysmorphic features, should raise the
suspect of GMS. Nosologically, it is thought that GMS constitutes a
heterogeneous group of disorders and several attempts has been
made to classify the syndrome according to age of onset and
severity of nephrotic syndrome, renal histopathology, prognosis,
progression of mental retardation, and structural brain abnormal-
ities.4,8 Because of the prominent and life-threatening renal
manifestations, GMS is relatively unknown to most pediatric
neurologists, although neurological involvement is the rule in this
condition.
We report two siblings presenting with severe encephalopathy,
featuring microcephaly, developmental delay, and early-onset
intractable epilepsy. Both patients manifested the clinical and
laboratory features of renal impairment only few years from the
onset, ﬁnally allowing the diagnosis of GMS. A particularly
devastating manifestation in our patients was the early-onset
refractory epilepsy. Review of the literature showed that age of
onset of epilepsy is largely variable in GMS, ranging from fewhours
to 5 years of life, seldom before the clinical evidence of renal
impairment.4–7 Different seizure types, including infantile spasms,
myoclonus, tonic-clonic, clonic, atonic, and focal seizures, have
been reported3,7–13; [Table 1]. EEG ﬁndings vary considerably and
include mainly a hypsarrhythmia pattern later followed by
multifocal epileptiform abnormalities. In almost all the patients,
epilepsy is drug-refractory with poor or no response to AEDs, used
in monotherapy or in combination.
The genetics of GMS remains unknown, despite the efforts to
characterize proteins that may be involved in its pathogenesis. It
has been reported reduced glomerular expression of some proteins
such as epithelial protein 1, synaptopodin, and nephrin, but this is
non-speciﬁc and a primary role of these proteins has been ruled
out.14 The possible defective role of several proteins of glomerular
basement membrane, including the family of laminins and
integrins were unsuccessfully studied.15 Further research is
required to clarify the pathogenesis of this dramatic condition.In summary, the diagnosis of GMS should be considered as
another, rare cause of severe, intractable epilepsy and multiple
neurological deﬁcits in infants, also in absence of renal manifesta-
tions. Early recognition of this syndrome is of paramount
importance especially for genetic counseling and family planning.
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